Epirubicin News and Research

RSS
Japanese researchers find new way for increasing effectiveness of drug delivery to brain tumors

Japanese researchers find new way for increasing effectiveness of drug delivery to brain tumors

New trial confirms superiority of triplet regimen over standard care in resectable esophago-gastric cancer

New trial confirms superiority of triplet regimen over standard care in resectable esophago-gastric cancer

Chemotherapy drug effective at preventing breast cancer's return, gives patients a better quality of life

Chemotherapy drug effective at preventing breast cancer's return, gives patients a better quality of life

Chemoradiotherapy and post-operative chemotherapy provide similar outcomes in gastric cancer patients

Chemoradiotherapy and post-operative chemotherapy provide similar outcomes in gastric cancer patients

DECT trial shows combination of epirubicin and trastuzumab improves outcomes in breast cancer patients

DECT trial shows combination of epirubicin and trastuzumab improves outcomes in breast cancer patients

Multi-gene test can help identify early breast cancer patients who can safely be spared chemotherapy

Multi-gene test can help identify early breast cancer patients who can safely be spared chemotherapy

Attaching Epirubicin drug to nanodiamonds eliminates chemoresistant cancer stem cells

Attaching Epirubicin drug to nanodiamonds eliminates chemoresistant cancer stem cells

Tumor-infiltrating lymphocytes may be good biomarker of response to trastuzumab in breast cancer

Tumor-infiltrating lymphocytes may be good biomarker of response to trastuzumab in breast cancer

New drug combination therapy effective for patients with HER2-positive breast cancer

New drug combination therapy effective for patients with HER2-positive breast cancer

Researchers develop nanodiamond delivery system for triple-negative breast cancer

Researchers develop nanodiamond delivery system for triple-negative breast cancer

Clinigen announces acquisition of Cardioxane from Novartis

Clinigen announces acquisition of Cardioxane from Novartis

Precision Therapeutics’ ChemoFx test feasible in cervical cancer

Precision Therapeutics’ ChemoFx test feasible in cervical cancer

Study identifies potential biomarkers associated with chemo resistant breast cancers

Study identifies potential biomarkers associated with chemo resistant breast cancers

GeparQuinto study data on bevacizumab plus chemotherapy in early breast cancer to be presented at 33rd CTRC-AACR

GeparQuinto study data on bevacizumab plus chemotherapy in early breast cancer to be presented at 33rd CTRC-AACR

Researchers present Phase III study of neoadjuvant therapy with trastuzumab and lapatinib for early breast cancer

Researchers present Phase III study of neoadjuvant therapy with trastuzumab and lapatinib for early breast cancer

Multiple presentations on nab-driven chemotherapy at 46th ASCO

Multiple presentations on nab-driven chemotherapy at 46th ASCO

Antiemetic-regimen with fosaprepitant injection provides similar protection against CINV as oral EMEND

Antiemetic-regimen with fosaprepitant injection provides similar protection against CINV as oral EMEND

EMEND indication helps women prevent CINV

EMEND indication helps women prevent CINV

Researchers identify new gene signature that predicts cancer recurrence in certain breast tumors

Researchers identify new gene signature that predicts cancer recurrence in certain breast tumors

INS cites FDA-approved Totect antidote for anthracycline extravasations

INS cites FDA-approved Totect antidote for anthracycline extravasations